Empagliflozin for reducing risk of kidney stones

Research shows this SLGT2 inhibitor may reduce stones in people with diabetes, though how is unclear. Kidney stones (urolithiasis) are commonly seen in primary care,...

Counselling patients on ineffective health apps

While health and fitness apps promise to improve the quality of life for users through positive behavioural changes, few systematic reviews have collated their...

PSA launches bold five-year plan for pharmacy

A new vision for the role of pharmacists launched PSA18 in Sydney today, with the unveiling of PSA’s Pharmacists in 2023: A Discussion Paper,...

PSA: pharmacists need support to improve Australia’s health

Following the announcement of this year’s Federal Election date, PSA looks forward to working with an incoming Government to support a healthier Australia by...

PSA successfully lobbies for pharmacist recommendations

Pharmacists have been recommended to access Medicare Benefits Schedule (MBS) items to manage medicines for patients who require complex care. The Pharmaceutical Society of Australia...

Three in four pharmacies register with My Health Record

Almost a third of My Health Record-connected pharmacies have already reported using the system to avoid a potentially adverse event, according to new data...